Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tri Prime Gene Pharmaceutical Co Days Payable Chart
Beijing Tri Prime Gene Pharmaceutical Co Annual Data
BJSE:920344 vs VRTX, REGN, MRNA: Days Payable Comparison
For the Biotechnology subindustry, Beijing Tri Prime Gene Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tri Prime Gene Pharmaceutical Co Days Payable vs Biotechnology Industry
Beijing Tri Prime Gene Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) has a Days Payable of 126.80 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beijing Tri Prime Gene Pharmaceutical Co and its competitors. This is 13% below median its historical median of 145.39. Over the past decade, Beijing Tri Prime Gene Pharmaceutical Co's Days Payable has ranged from 6.34 to 688.62. According to the industry distribution chart, Beijing Tri Prime Gene Pharmaceutical Co ranks #262 out of 707 companies in the Biotechnology industry, placing it in the top 37.1%.
Is Beijing Tri Prime Gene Pharmaceutical Co's Days Payable too high?
Beijing Tri Prime Gene Pharmaceutical Co's current Days Payable of 126.80 is 13% below median its 10-year median of 145.39. Over the past 10 years, this metric has ranged from a low of 6.34 to a high of 688.62. The Biotechnology industry median Days Payable is 111.24. Beijing Tri Prime Gene Pharmaceutical Co's value of 126.80 is 14% above this industry median. Based on the distribution chart, Beijing Tri Prime Gene Pharmaceutical Co ranks #262 out of 707 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Beijing Tri Prime Gene Pharmaceutical Co has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Tri Prime Gene Pharmaceutical Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Tri Prime Gene Pharmaceutical Co ranks #262 out of 707 companies for Days Payable. This puts Beijing Tri Prime Gene Pharmaceutical Co in the upper half of its industry. The industry median Days Payable is 111.24. Beijing Tri Prime Gene Pharmaceutical Co's value of 126.80 is 14% above this benchmark. Historically, Beijing Tri Prime Gene Pharmaceutical Co's own Days Payable has ranged from 6.34 to 688.62 over the past decade. While the company's 10-year median is 145.39 vs. the industry median of 111.24, Beijing Tri Prime Gene Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 111.24, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tri Prime Gene Pharmaceutical Co's current Days Payable of 126.80 is 14% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Beijing Tri Prime Gene Pharmaceutical Co and its competitors. For the Biotechnology industry, the median Days Payable is 111.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tri Prime Gene Pharmaceutical Co's current Days Payable is 126.80, which is 13% below median its own 10-year median of 145.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tri Prime Gene Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) is currently considered Fairly Valued. The stock's GF Value™ is ¥20.93, compared to a current price of ¥19.11 — trading 8.7% below its estimated fair value. The current Days Payable is 126.80, which is 13% below median its 10-year median of 145.39 and 14% above the Biotechnology industry median of 111.24. Beijing Tri Prime Gene Pharmaceutical Co's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344), the current Days Payable is 126.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tri Prime Gene Pharmaceutical Co (BJSE:920344) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tri Prime Gene Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥19.11 is trading 8.7% below its estimated GF Value™ of ¥20.93.
GuruFocus considers Beijing Tri Prime Gene Pharmaceutical Co to be Fairly Valued.
Key valuation signals for BJSE:920344:
Days Payable: 126.80 (13% below median its 10-year median of 145.39)
GF Value™: ¥20.93 vs. price of ¥19.11 (8.7% below fair value)
Industry Position: 14% above the Biotechnology median (#262 of 707)
No single metric tells the full story. See the BJSE:920344 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tri Prime Gene Pharmaceutical Co Ltd is mainly engaged in the research, development, production, and sales of medical biotechnology products, including genetic engineering drugs, genetic engineering vaccines, and diagnostic reagents, and is engaged in related technical trade and technical consulting services. Its product line comprises Yundex Spray, Yundex Eye Drops, Yundexol Powder Injection, and Yundexol Water Injection.
85GF Score
Get the complete analysis for BJSE:920344
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920344 has been successfully added to your 
